Skip to main content
Clinical Trials/JPRN-UMIN000038108
JPRN-UMIN000038108
Completed
未知

Randomized controlled trial on the effectiveness of acupuncture for peripheral neuropathy by taxane anticancer drug treatment (multicenter collaborative research) - AcuNEXT

Shimane University0 sites105 target enrollmentSeptember 26, 2019

Overview

Phase
未知
Intervention
Not specified
Conditions
Peripheral neuropathy caused by anticancer drugs
Sponsor
Shimane University
Enrollment
105
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 26, 2019
End Date
March 31, 2025
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\) Peripheral neuropathy falls under any of the following. Neurologic symptoms that may be caused by sciatica or radiculopathy Neurologic symptoms thought to be caused by peripheral nerve strangulation such as tarsal tunnel syndrome Extremity sensory abnormalities that may be caused by cerebrovascular disorders Peripheral peripheral circulatory disturbance based on obstructive arteriosclerosis or Raynaud's disease Diabetic neuropathy Numbness worsens after bathing. 2\) It is difficult to receive acupuncture due to metal allergy. 3\) Major organ functions such as liver function, kidney function, pulmonary function, and hemostatic function are severely impaired 4\) A woman who is or may be pregnant. 5\) Concomitant with psychosis or symptom, it is difficult to understand clinical trials. 6\) In addition, the doctor responsible for research (sharing) determined that it was inappropriate.

Outcomes

Primary Outcomes

Not specified

Similar Trials